Technical Analysis for MNTA - Momenta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 12.97 -8.01% -1.13
MNTA closed down 8.01 percent on Friday, March 22, 2019, on 80 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical MNTA trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 21 Crossed Above 20 DMA Bullish -8.01%
Mar 21 1,2,3 Pullback Bullish Bullish Swing Setup -8.01%
Mar 21 180 Bullish Setup Bullish Swing Setup -8.01%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -8.01%
Mar 21 Pocket Pivot Bullish Swing Setup -8.01%

Older signals for MNTA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Momenta Pharmaceuticals, Inc., a biotechnology company, engages in the structural characterization, process engineering, and biologic systems analysis of complex molecules. Its complex molecules include polysaccharides, polypeptides, and proteins and antibodies. The company's complex generics programs comprise Enoxaparin sodium injection, a generic version of Lovenox that is used for the prevention and treatment of deep vein thrombosis, and to support the treatment of acute coronary syndromes; and M356, a generic version of Copaxone, which is a glatiramer acetate injection indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis. Its biosimilars programs include M923, a biosimilar for autoimmune and inflammatory diseases; M834 for autoimmune and inflammatory diseases; and M511, a monoclonal antibody for oncology. The company's novel products comprise M402, a novel heparan sulfate mimetic that binds to various growth factors, adhesion molecules, and chemokines to inhibit tumor angiogenesis, progression, and metastasis; and the sialylation technology, which is a discovery program that is intended to modify immunoglobulin G antibodies in intravenous immunoglobulin, a drug to treat autoimmune and inflammatory diseases. It has collaboration agreements with Sandoz AG; Baxter International, Inc.; Baxter Healthcare Corporation; and Baxter Healthcare SA. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology Immunology Antibodies Immune System Tumor Antibody Monoclonal Antibody Autoimmunity Autoimmune And Inflammatory Diseases Glycoproteins Biosimilar Deep Vein Thrombosis Metastasis Acute Coronary Syndromes Immunoglobulin Therapy Relapsing Remitting Multiple Sclerosis
Is MNTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 32.2
52 Week Low 9.55
Average Volume 598,675
200-Day Moving Average 18.4549
50-Day Moving Average 12.8884
20-Day Moving Average 13.9885
10-Day Moving Average 13.991
Average True Range 0.7402
ADX 33.29
+DI 23.4258
-DI 22.1123
Chandelier Exit (Long, 3 ATRs ) 13.8894
Chandelier Exit (Short, 3 ATRs ) 14.9806
Upper Bollinger Band 14.9864
Lower Bollinger Band 12.9906
Percent B (%b) -0.01
BandWidth 14.267434
MACD Line 0.2065
MACD Signal Line 0.3395
MACD Histogram -0.1331
Fundamentals Value
Market Cap 957.1 Million
Num Shares 73.8 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -20.27
Price-to-Sales 9.20
Price-to-Book 2.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.77
Resistance 3 (R3) 14.96 14.56 14.47
Resistance 2 (R2) 14.56 14.10 14.46 14.37
Resistance 1 (R1) 13.76 13.82 13.56 13.57 14.27
Pivot Point 13.36 13.36 13.26 13.26 13.36
Support 1 (S1) 12.56 12.90 12.36 12.37 11.67
Support 2 (S2) 12.16 12.62 12.06 11.57
Support 3 (S3) 11.36 12.16 11.47
Support 4 (S4) 11.17